BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Tesla
TSLA
|
+$468M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$266M |
| 5 |
Abbott
ABT
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$609M |
| 2 |
Apple
AAPL
|
+$577M |
| 3 |
Visa
V
|
+$476M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$434M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.37% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 6.83% |
| 4 | Healthcare | 6.12% |
| 5 | Communication Services | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
HF Foods Group
HFFG
$99.2M
| $24K | ﹤0.01% |
4,544
-12,061
| -73% | -$75K |
|
3352
Stoke Therapeutics
STOK
$2.13B
| $23.9K | ﹤0.01% |
710
-3,477
| -83% | -$123K |
|
3353
Solid Biosciences
SLDB
$972M
| $23.8K | ﹤0.01% |
433
-290
| -40% | -$19.2K |
|
3354
Siebert Financial
SIEB
$71.1M
| $23.6K | ﹤0.01% |
4,909
+3,669
| +296% | +$15.2K |
|
|
CTT
3355
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $23.6K | ﹤0.01% |
2,016
-18,796
| -90% | -$218K |
|
3356
Hurco Companies Inc
HURC
$144M
| $23.5K | ﹤0.01% |
671
-2,598
| -79% | -$90.4K |
|
|
SPNE
3357
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $23.4K | ﹤0.01% |
1,143
-9,739
| -89% | -$200K |
|
3358
Mayville Engineering Co
MEC
$596M
| $23.4K | ﹤0.01% |
1,165
-2,965
| -72% | -$52.3K |
|
3359
Ardelyx
ARDX
$1.03B
| $23.4K | ﹤0.01% |
3,085
-15,334
| -83% | -$113K |
|
|
PAMT
3360
PAMT Corp
PAMT
$279M
| $23.4K | ﹤0.01% |
1,772
-1,096
| -38% | -$15.9K |
|
|
AKRO
3361
DELISTED
Akero Therapeutics
AKRO
| $23.3K | ﹤0.01% |
941
-781
| -45% | -$21.9K |
|
3362
VistaGen Therapeutics
VTGN
$11.6M
| $23.2K | ﹤0.01% |
+246
| New | +$18.2K |
|
3363
Funko
FNKO
$331M
| $23.2K | ﹤0.01% |
1,089
-11,133
| -91% | -$253K |
|
3364
KVH Industries
KVHI
$142M
| $23.2K | ﹤0.01% |
1,883
-5,761
| -75% | -$77.9K |
|
3365
Turning Point Brands
TPB
$1.73B
| $23.1K | ﹤0.01% |
505
-1,009
| -67% | -$46.7K |
|
|
LAND
3366
Gladstone Land Corp
LAND
$353M
| $22.6K | ﹤0.01% |
941
-5,353
| -85% | -$121K |
|
3367
CorMedix
CRMD
$557M
| $22.5K | ﹤0.01% |
3,281
-642
| -16% | -$5.11K |
|
3368
NRC Health Common Stock
NRC
$456M
| $22.5K | ﹤0.01% |
490
-1,262
| -72% | -$60K |
|
|
JNCE
3369
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $22.5K | ﹤0.01% |
3,303
-4,524
| -58% | -$37.6K |
|
3370
Alpha and Omega Semiconductor
AOSL
$1.09B
| $22.5K | ﹤0.01% |
739
-9,326
| -93% | -$287K |
|
3371
ACM Research
ACMR
$5.66B
| $22.4K | ﹤0.01% |
657
+375
| +133% | +$10.3K |
|
3372
Viper Energy
VNOM
$15.2B
| $22.3K | ﹤0.01% |
1,184
+310
| +35% | +$5.56K |
|
3373
Zymeworks
ZYME
$1.77B
| $22.3K | ﹤0.01% |
642
+290
| +82% | +$9.2K |
|
3374
MasterCraft Boat Holdings
MCFT
$600M
| $22.2K | ﹤0.01% |
845
-1,626
| -66% | -$45.4K |
|
|
ONCT
3375
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $22.1K | ﹤0.01% |
+233
| New | +$27.6K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2021 Portfolio in Review
As of Q2 2021, BNP Paribas Financial Markets held 4,172 positions worth $75.6B, up 11% from $68.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BNP Paribas Financial Markets's Q2 2021 filing shows 175 new, 1,539 increased, 1,937 reduced and 124 closed positions. Its largest new stake was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M. The largest sale was Invesco QQQ Trust, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2021 buy was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $1.06B increase.
- BNP Paribas Financial Markets's biggest Q2 2021 reduction was Invesco QQQ Trust, cutting an estimated $609M.
- BNP Paribas Financial Markets fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $123M.
- BNP Paribas Financial Markets's ten largest holdings make up 13% of its $75.6B portfolio in Q2 2021.
- BNP Paribas Financial Markets opened 175 new positions and closed 124 in Q2 2021.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $75.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2021, filed 10 Aug 2021.